Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers D > Headlines for DexCom, Inc. > News item |
JPMorgan plans contingent interest autocalls on Dexcom
By Sarah Lizee
Olympia, Wash., Jan. 23 – JPMorgan Chase Financial Co. LLC plans to price autocallable contingent interest notes due Feb. 10, 2021 linked to Dexcom, Inc. stock, according to a 424B2 filing with the Securities and Exchange Commission.
The notes will pay a contingent quarterly coupon at an annual rate of 14% if the stock closes at or above its 61.25% coupon barrier on the review date for that quarter, in which case investors will also receive any previously unpaid coupons.
The notes will be called at par if the stock closes at or above its initial level on any review date other than the final date.
The payout at maturity will be par unless the stock finishes below its 61.25% trigger level, in which case investors will be fully exposed to any losses.
The notes are guaranteed by JPMorgan Chase & Co.
J.P. Morgan Securities LLC is the agent.
The notes will price on Jan. 24.
The Cusip number is 48132HVJ8.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.